BioNexus Gene Lab (BGLC) Non-Current Deferred Tax Liability (2018 - 2024)
BioNexus Gene Lab recorded quarterly Non-Current Deferred Tax Liability of $13646.0 in Q3 2024, up 14.5% quarter-over-quarter from $11918.0 in Q2 2024, and down 52.75% year-over-year from $28880.0 in Q4 2023.
BioNexus Gene Lab's Non-Current Deferred Tax Liability history runs 7 years deep, the most recent figure standing at $13646.0 for Q3 2024.
- In Q3 2024, Non-Current Deferred Tax Liability fell 52.75% year-over-year to $13646.0; the TTM figure through Sep 2024 stood at $13646.0 (down 52.75% YoY), while the FY2023 annual figure was $12255.0, down 60.3% from the prior year.
- Non-Current Deferred Tax Liability came in at $13646.0 for Q3 2024 at BioNexus Gene Lab, up from $11918.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $30866.0 in Q4 2022 to a low of $1796.0 in Q3 2021.
- A 5-year average of $17840.3 and a median of $19593.5 in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability surged 1452.12% in 2022 and plunged 61.16% in 2024, its largest moves.
- BioNexus Gene Lab's Non-Current Deferred Tax Liability stood at $1872.0 in 2020, then surged by 1417.95% to $28416.0 in 2021, then increased by 8.62% to $30866.0 in 2022, then plunged by 60.3% to $12255.0 in 2023, then climbed by 11.35% to $13646.0 in 2024.
- According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $13646.0, $11918.0, and $11916.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Linde | 230.79 Bn | 226.84 Bn | 4.26 Bn |
| 2 | Chemical & Mining Co Of Chile | 127.66 Bn | 124.93 Bn | 778.60 Mn |
| 3 | Sherwin Williams | 72.51 Bn | 72.30 Bn | 2.78 Bn |
| 4 | Ecolab | 70.96 Bn | 70.34 Bn | 1.85 Bn |
| 5 | Air Products & Chemicals | 62.15 Bn | 63.70 Bn | 987.40 Mn |
| 6 | Ppg Industries | 25.04 Bn | 23.57 Bn | 1.66 Bn |
| 7 | LyondellBasell Industries | 21.62 Bn | 21.73 Bn | 701.00 Mn |
| 8 | Albemarle | 20.26 Bn | 19.42 Bn | 500.97 Mn |
| 9 | DuPont de Nemours | 19.45 Bn | 19.56 Bn | 602.00 Mn |
| 10 | BioNexus Gene Lab | 5.34 Mn | 1.38 Mn | -790.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 13,646.00 |
| Sep 30, 2024 | 13,646.00 |
| Jun 30, 2024 | 11,918.00 |
| Jun 30, 2024 | 11,918.00 |
| Mar 31, 2024 | 11,916.00 |
| Mar 31, 2024 | 11,916.00 |
| Dec 31, 2023 | 12,255.00 |
| Dec 31, 2023 | 12,255.00 |
| Sep 30, 2023 | 28,880.00 |
| Sep 30, 2023 | 28,880.00 |
| Jun 30, 2023 | 29,047.00 |
| Jun 30, 2023 | 29,047.00 |
| Mar 31, 2023 | 30,678.00 |
| Mar 31, 2023 | 30,678.00 |
| Dec 31, 2022 | 30,866.00 |
| Dec 31, 2022 | 30,866.00 |
| Sep 30, 2022 | 25,541.00 |
| Sep 30, 2022 | 25,541.00 |
| Jun 30, 2022 | 26,850.00 |
| Jun 30, 2022 | 26,850.00 |
| Mar 31, 2022 | 28,140.00 |
| Mar 31, 2022 | 28,140.00 |
| Dec 31, 2021 | 28,416.00 |
| Dec 31, 2021 | 28,416.00 |
| Sep 30, 2021 | 1,796.00 |
| Sep 30, 2021 | 1,796.00 |
| Jun 30, 2021 | 1,811.00 |
| Jun 30, 2021 | 1,811.00 |
| Mar 31, 2021 | 1,813.00 |
| Mar 31, 2021 | 1,813.00 |
| Dec 31, 2020 | 1,872.00 |
| Dec 31, 2020 | 1,872.00 |
| Sep 30, 2019 | 4,433.00 |
| Sep 30, 2019 | 4,433.00 |
| Mar 31, 2019 | 4,549.00 |
| Mar 31, 2019 | 4,549.00 |
| Dec 31, 2018 | 4,485.00 |
| Dec 31, 2018 | 4,485.00 |